Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations

• Heterozygous inactivating mutations in ribosomal protein genes (RPGs) are associated with hematopoietic and developmental abnormalities, activation of p53, and altered risk of cancer in humans and model organisms. Here we performed a large-scale analysis of cancer genome data to examine the frequency and selective pressure of RPG lesions across human cancers. We found that hemizygous RPG deletions are common, occurring in about 43% of 10,744 cancer specimens and cell lines. Consistent with p53-dependent negative selection, such lesions are underrepresented in TP53-intact tumors (P ≪ 10−10), and shRNA-mediated knockdown of RPGs activated p53 in TP53-wild-type cells. In contrast, we did not see negative selection of RPG deletions in TP53-mutant tumors. RPGs are conserved with respect to homozygous deletions, and shRNA screening data from 174 cell lines demonstrate that further suppression of hemizygously deleted RPGs inhibits cell growth. Our results establish RPG haploinsufficiency as a strikingly common vulnerability of human cancers that associates with TP53 mutations and could be targetable therapeutically.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

cancer

ribosomal gene haploinsufficiency

ribosome function

protein p53

ribosome protein

short hairpin RNA

article

cancer cell line

cancer genetics

cancer tissue

cell growth

cell line

controlled study

disease association

gene deletion

gene mutation

gene silencing

genetic screening

haploinsufficiency

hemizygote

homozygote

human

human cell

malignant neoplasm

nonhuman

ribosomal protein gene

TP53 gene

Publikations- och innehållstyp

art (ämneskategori)

ref (ämneskategori)